Effective Mechanisms of Wu-Chu-Yu Tang on Gastroesophageal Disorder

Last updated: October 4, 2019
Sponsor: China Medical University Hospital
Overall Status: Active - Recruiting

Phase

4

Condition

Gastroesophageal Reflux Disease (Gerd)

Heartburn (Pediatric)

Esophageal Disorders

Treatment

N/A

Clinical Study ID

NCT04118647
CMUH108-REC2-101
  • Ages 20-75
  • All Genders

Study Summary

Gastroesophageal reflux disorder (GERD) is due to gastric content reflux to esophagus cause symptom and complication including intra-esophagus such as reflux esophagitis, and extra-esophagus such as cough etc. Because the changes of dietary habit, and improvement of examination skill and data analysis, the prevalence of GERD increased 2.5 multiple from 1995 to 2002, and suggesting the prevalence is 25% in Taiwan community.

The etiology of GERD is multi-effect, such as transient lower esophageal sphincter relaxation and abnormal pressure of lower esophageal sphincter, which may induced the esophageal mucosal injury by gastric acid, bile or pancreases enzyme.

Wu-Chu-Yu tang consists of Evodia fargesii Dode (Evodia Fruit), Panax ginseng C. (Ginseng), Ziziphus jujube Mill (Chinses Date), Zingiber officinale Rosee (Fresh Ginger).According to "I-Fang-Chi-Chieh" and "Shanghonzobinglun" recordings that Wu-Chu-Yu tang can treat vomiting, and also can relax gastric tonicity and can enhance peristalsis of stomach. According to Randomized, double blind, placebo control trial to evaluate the efficacy of Wu-Chu-Yu Tang on gastroesophageal reflux disease, we know the Wu-Chu-Yu tang have the equivalent effect proton pump inhibitor omeprazole. But, the mechanism of Wu-Chu-Yu tang is still unknown.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Gender：male or female.

  2. Age：from 20 years old (inclusive) to 75 years old (inclusive).

  3. Diagnosis of gastroesophageal reflux disease.

  4. there is a heartburn or acid regurgitation phenomenon.

  5. After detailed description of the entire research purpose or process, voluntarilyparticipate in the study and sign the consent form.

Exclusion

Exclusion Criteria:

  1. Exclude peptic ulcers, gallstones (including intrahepatic and common bile ducts) andmajor diseases such as: cancer, congestive hear failured NYHA class>II, COPD attack.

  2. Barrett's esophagus, narrow esophagus or caustic injury of upper gastrointestinaltract.

  3. History of esophagus and gastroduodenal surgery.

  4. Tarry stool suspected gastrointestinal bleeding.

  5. History of alcohol or drug abuse.

  6. Patients with a history of allergies to the test drug.

  7. Can not cooperate with mental illness.

  8. Pregnant women or women who are breastfeeding.

  9. Liver function SGOT and SGPT are more than twice the normal value.

  10. renal function test BUN, Creatinine is greater than the normal value.

Study Design

Total Participants: 55
Study Start date:
October 01, 2019
Estimated Completion Date:
September 30, 2021

Connect with a study center

  • China Medical University Hospital

    Taichung, North District 40447
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.